Additionally, total pivotal biotargets of puerarin to treat COVID‐19 were identified, including new anti–COVID‐19 targets that may comprise FOS, PTGS, PRKCB, PRKCA and NOS3. This evidence concerns the gene PRKCA and COVID-19.